OBVAMconcussion-related convergence insufficiency (CONC-CI)CONC-CINCT05262361
…difference was observed for NPC, PFV or CISS (p=1.0).Conclusion OBVAM therapy is effective in improving the NPC, PFV and symptoms in …
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 601–660 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Sulfasalazine6Tisagenlecleucel6Zonisamide6erlotinib6hydromorphone6oxcarbazepine6Botulinum Toxin A6Calcineurin inhibitors6IL-76MMAE6PD-1 inhibitors6PLEX6Saline6Tezacaftor6abiraterone6anticoagulant6antihypertensive medications6dexketoprofen6oral steroids6phenytoin6sodium bicarbonate6Baclofen6Fluoroquinolone6Itraconazole6PPI6PRAME6Rapamycin6antiseizure medications6mephedrone6n-butyl cyanoacrylate6renin-angiotensin system inhibitors6Beta blocker6Entecavir6Oral corticosteroids6Valganciclovir6anti-seizure medications6cabotegravir/rilpivirine6citalopram6dextran sulfate sodium6penicillins6stimulants6teicoplanin6HRT5Treprostinil5Glimepiride5Orlistat5NKTR-2555Emicizumab5Efgartigimod5Sarilumab5Etrasimod5CAB-LA5D-Dimer5GDF-155TMZ5TAF5Darolutamide5ESPB5Marijuana53TC5
Articles mentioning drugs
10,506 articles · page 97 of 876ARNIβ-blockerARBACEiheart failure-relatedquadruple therapyheart failure with reduced ejection fraction
…e therapy at discharge in 2022. Prescription rates for ACEi/ARB/ARNI (67%), beta-blockers (89%), MRAs (40%), and SGLT2 inhibitors (4…
EazyplexGeneXpertChlamydia trachomatisNeisseria gonorrhoeaesyndromic managementNG
…ed, respectively. All results had specificity ≥98.5%.Conclusion Eazyplex was highly specific but moderately sensitive in detecting NG an…
belimumabanifrolumabrituximabsystemic lupus erythematosusSLECOVID-19herpes zoster
…fections, most notably sepsis and influenza, when compared with belimumab, and these differences became more evident with longer exposure…
DORISDORIS-PLUSlupusSLECNS lupuslupus arthritis
…ts The Task Force agreed on the following verbatim definition: ‘DORIS+ represents the state beyond clinical remission that is a meani…
RituximabprednisoloneRTXSystemic Lupus ErythematosusSLElupus nephritislupusUnit
… (SLE) is an autoimmune disease driven by B-cell dysregulation. Rituximab (RTX) depletes B cells through complement-dependent cytotoxicit…
anifrolumabcorticosteroidSLE
… and consistently after 12 months. These findings suggests that anifrolumab could reduce organ damage accumulation, supporting the potentia…
LMWHLDASALMWH-treatedprednisoloneKarolinska University Hospitalsystemic lupus erythematosusSLElupus nephritis
…previa (PP) were recorded in the MB group, all treated with low LMWH prophylactic dose. Two MB and 5 non-MB patients experienced PE …
Mycophenolate mofetilMMFintravenous cyclophosphamideCYCLupus NephritisLN
…Objectives Mycophenolate mofetil (MMF) and intravenous cyclophosphamide (CYC) are recommended th…
mycophenolate mofetilvoclosporintacrolimusbelimumabmethotrexateazathioprineprednisoneANISLESLE-DAS+2 more
…, ANI was administered concomitantly with antimalarials (n=16), mycophenolate mofetil (n=11), tacrolimus (n=4), azathioprine (n=2), methotrexate (n=1…
voclosporinobinutuzumabbelimumabanifrolumabmycophenolate mofetilrituximabsystemic lupus erythematosusClass V diseaseEnlight-LN registryClass IV disease+2 more
…omitant immunosuppressive biologics in LN patients treated with voclosporin. This is notable given the unique and possibly synergistic effe…
prednisonebelimumabrituximabazathioprinemycophenolatemethotrexateGCSystemic Lupus ErythematosusSLERELESSER-PROS registry
…3), organ damage (SLICC/ACR Damage Index) (SDI), treatments and prednisone dosages for every visit were collected.We compared patients nev…